10% discount using “MY10” code for order above $499 + Free Shipping
Price range: $80.00 through $420.00
Brand name – Vidalista 40mg
Generic name – Tadalafil 40mg
Manufacturer – Centurian Laboratories
Packaging – 10 tablets in 1 strip
Vidalista 40mg is an oral tablet containing Tadalafil as its active ingredient. Centurion Laboratories Pvt. Ltd., an established Indian pharmaceutical company, manufactures this medicine. Tadalafil belongs to a class of drugs called phosphodiesterase type 5 inhibitors, commonly known as PDE5 inhibitors. These drugs increase blood flow to the penis during sexual stimulation. As a result, they help men achieve and maintain a firm erection sufficient for satisfying sexual activity.
Men and healthcare professionals considering Vidalista 40mg must understand one essential fact before proceeding. The internationally recognized maximum approved dose of Tadalafil for erectile dysfunction is 20mg per day on an as-needed basis. Major global regulatory authorities establish this limit. These include the United States Food and Drug Administration, the European Medicines Agency, and equivalent bodies worldwide. Vidalista 40mg therefore exceeds this approved maximum dose by a factor of two.
This does not mean the 40mg dose carries universal prescription or recommendation. It means men must approach this strength with a heightened level of medical caution. No man should take Vidalista 40mg without thorough prior assessment and explicit written prescription from a qualified licensed doctor. That doctor must review the full clinical picture before making any prescribing decision. Men must never self-prescribe this dose or purchase it without a valid prescription.
Doctors sometimes consider Vidalista 40mg for adult men with erectile dysfunction whose condition has not responded adequately to the standard maximum approved dose of 20mg. In these cases, the supervising physician determines that a higher dose may be clinically justified given the individual patient’s circumstances. Erectile dysfunction is the consistent inability to achieve or maintain a firm erection sufficient for satisfactory sexual intercourse. It affects millions of men globally. Physical causes include advanced diabetes, severe vascular disease, cardiovascular conditions, hormonal disorders, and neurological damage. Significant psychological contributors also play a role in many cases.
Vidalista 40mg exceeds the internationally approved maximum Tadalafil dose. Because of this, the safety considerations are significantly more complex than at approved dose levels. The cardiovascular risks, drug interaction risks, and dose-dependent side effects all increase at this strength. Doctors who consider this dose must conduct a comprehensive cardiovascular assessment. They must also review every medicine the patient takes, evaluate kidney and liver function, and weigh the potential clinical benefit against the elevated risk profile. This thorough evaluation is not optional. It is an absolute clinical requirement at this dose level.
Centurion Laboratories manufactures Vidalista 40mg following established pharmaceutical protocols. However, the existence of a pharmaceutical product does not constitute a medical recommendation or regulatory endorsement of its use. Men who find the approved 20mg dose insufficient must discuss this with their doctor rather than independently stepping up to a higher strength. The doctor will assess whether correctable factors are responsible for the inadequate response. These may include incorrect timing, food interactions, psychological contributors, or treatable underlying conditions. Only after ruling out these factors should any physician consider a dose above the approved maximum.
During sexual stimulation, the nervous system releases nitric oxide into the smooth muscle tissue of the penis. Nitric oxide activates an enzyme called guanylate cyclase. This enzyme increases levels of a chemical messenger called cyclic guanosine monophosphate, abbreviated as cGMP. The cGMP relaxes smooth muscle cells in the corpus cavernosum, which is the spongy erectile tissue inside the penis. Blood vessels in the penile tissue widen. Blood flows freely into the corpus cavernosum and produces a firm erection.
In men with erectile dysfunction, an enzyme called PDE5 breaks down cGMP prematurely. This rapid degradation reduces smooth muscle relaxation, restricts blood vessel dilation, and limits blood flow to the penile tissue. In men with severe or treatment-resistant erectile dysfunction, this PDE5-mediated disruption is especially aggressive. Significant underlying vascular damage makes this problem worse. Even maximum approved doses of PDE5 inhibitors may not produce sufficient cGMP preservation to overcome the severity of their physiological impairment.
Tadalafil, the active ingredient in Vidalista 40mg, directly inhibits the PDE5 enzyme. By blocking PDE5, it prevents the premature breakdown of cGMP. Blood vessels in the penile tissue remain relaxed and dilated as a result. Blood flows freely into the corpus cavernosum, supporting a firm erection during sexual activity. At the 40mg dose, the degree of PDE5 inhibition surpasses that achieved at the approved 20mg maximum. This stronger inhibition may produce a more pronounced erectile response in men whose physiology requires it. However, it also produces correspondingly stronger effects on blood pressure and other organ systems throughout the body. This is precisely why this dose carries elevated safety concerns.
Tadalafil differs from other PDE5 inhibitors primarily because of its exceptionally long duration of action. Sildenafil and Vardenafil last approximately four to six hours. Tadalafil, by contrast, remains effective in the body for up to 36 hours after a single dose. At the 40mg dose, this extended duration is maintained. Furthermore, the half-life of Tadalafil means higher doses take longer to eliminate from the body fully. This prolonged exposure amplifies both the therapeutic effect and the risk of side effects across the full elimination period.
Vidalista 40mg does not produce an automatic erection at any time. Sexual stimulation must always occur first for the medicine to enhance erectile function. The tablet removes the biochemical barrier of premature cGMP degradation. Without natural sexual arousal, the erection pathway does not activate. Men therefore do not experience unwanted or artificially forced erections during ordinary daily activities.
All dosage information below applies only to men under the direct and ongoing supervision of a licensed qualified physician. That physician must have explicitly assessed and approved use of this dose. Men must never self-prescribe Vidalista 40mg. Additionally, men must never take this dose simply because a standard dose appeared insufficient without first consulting their doctor. A doctor must identify and rule out all correctable causes of treatment failure before any discussion of above-maximum dosing begins.
In clinical situations where a qualified physician determines that above-approved-maximum Tadalafil dosing may be appropriate, the doctor conducts a full cardiovascular assessment first. After that, the doctor reviews all current medicines for interaction risks and evaluates kidney and liver function. The doctor then documents the clinical rationale for exceeding the approved dose. Frequency of use, timing, and monitoring requirements are all determined individually for each patient. No standard universal dosing schedule applies to above-maximum doses in the same way that approved dose guidelines apply to the 10mg and 20mg strengths.
When a doctor has explicitly approved use of Vidalista 40mg, men typically take it orally with a full glass of water approximately 30 to 60 minutes before planned sexual activity. Tadalafil has minimal food interaction. A high-fat meal does not significantly delay or reduce its absorption. However, men must avoid grapefruit and grapefruit juice throughout treatment. Grapefruit inhibits the CYP3A4 liver enzyme responsible for metabolizing Tadalafil. At the already elevated 40mg dose, grapefruit-induced increases in Tadalafil blood concentration carry a significantly higher safety risk than at approved dose levels.
Even under medical supervision, Vidalista 40mg must never exceed one tablet in any 24-hour period. Men must also never combine it with any other PDE5 inhibitor under any circumstances. Combining PDE5 inhibitors produces additive blood pressure-lowering effects that can become life-threatening. Additionally, Tadalafil’s half-life is approximately 17.5 hours. A 40mg dose therefore takes significantly longer to clear than a 20mg dose. The prescribing doctor must factor this prolonged systemic exposure into all subsequent dosing decisions.
Elderly men above 65 years of age must not use Vidalista 40mg without the most rigorous individual assessment. Age-related declines in liver and kidney function slow Tadalafil elimination substantially. Tadalafil accumulation at the 40mg dose in elderly patients can reach levels that produce serious cardiovascular and systemic effects. Patients with any degree of kidney or liver impairment require especially careful evaluation. Patients with severe kidney or liver disease must not use this dose under any circumstances.
Always inform the doctor about every medicine currently in use before any discussion of Vidalista 40mg. Interactions that produce modest blood concentration increases at the approved 20mg dose produce proportionally greater and potentially dangerous increases at the 40mg level. Medicines of particular concern include all nitrates, all alpha-blockers, antifungals that inhibit CYP3A4, HIV protease inhibitors, and CYP3A4-inhibiting antibiotics. The interaction risk profile at this above-maximum dose demands a more comprehensive medicine review than at any approved dose level. Never self-adjust the dose without direct medical approval.
Vidalista 40mg produces higher peak blood concentrations of Tadalafil than the approved 20mg maximum. Consequently, all dose-dependent side effects occur with greater frequency and potentially greater intensity at this strength. Regulatory authorities have not approved this level of Tadalafil exposure as a standard safe dose for the general population. Men considering or using this dose must fully understand and prepare for an elevated side effect profile compared to all approved Tadalafil doses.
Common side effects at the 40mg dose include headache, facial flushing or warmth, nasal congestion, indigestion or stomach discomfort, dizziness, and back pain or muscle aches. Headache is the most frequently reported complaint across all PDE5 inhibitors and may be more severe at this higher dose. These effects occur with greater frequency and greater intensity at 40mg than at the approved 20mg maximum. Men must report all side effects to their supervising doctor throughout treatment at this dose level.
Back pain and muscle aches are more consistently associated with Tadalafil than with any other PDE5 inhibitor. At the 40mg dose, these effects are expected to be more frequent and potentially more pronounced than at approved doses. Tadalafil’s inhibitory effect on PDE11 in skeletal muscle and other tissues produces them. At this higher dose, the PDE11 inhibition is correspondingly stronger. Men who experience significant or persistent musculoskeletal discomfort must report this to their doctor without delay for dose review.
At the 40mg dose, Tadalafil’s blood pressure-lowering effect is substantially stronger than at the approved 20mg maximum. Men with any pre-existing cardiovascular condition, borderline blood pressure, or those taking other medicines that affect blood pressure face a significantly elevated risk of a clinically meaningful blood pressure drop. This blood pressure reduction can cause dizziness, fainting, and in vulnerable individuals, serious cardiovascular events including myocardial infarction or stroke. Doctors must conduct thorough cardiovascular assessment and maintain ongoing monitoring throughout use of this above-maximum dose.
Although rare, certain serious side effects require urgent medical care. Men must contact a doctor or emergency services immediately if they experience any of the following:
Men taking nitrate medicines such as nitroglycerin, isosorbide mononitrate, or isosorbide dinitrate must never take Vidalista 40mg under any circumstances. The combination of Tadalafil at this above-maximum dose with any nitrate medicine produces a severe and potentially immediately fatal drop in blood pressure. This absolute contraindication applies regardless of the dose or frequency of the nitrate medicine. No safe combination of Vidalista 40mg with any nitrate exists at any dose level.
Doctors sometimes consider Vidalista 40mg for men with severe or treatment-resistant erectile dysfunction who have not responded to the approved maximum Tadalafil dose of 20mg. A qualified physician must provide direct supervision throughout use. It works through the same PDE5 inhibition mechanism as all Tadalafil products. Because it exceeds the internationally approved maximum dose, it requires more thorough medical evaluation and closer ongoing monitoring than standard approved doses.
No. The internationally approved maximum as-needed dose of Tadalafil is 20mg per day. Vidalista 40mg exceeds this approved maximum. Major global regulatory agencies including the FDA and EMA have not approved 40mg as a standard dose for erectile dysfunction. Men must clearly understand this before considering this product. Only direct, explicit medical supervision with full awareness of its above-maximum-dose status makes any use of this product clinically responsible.
In exceptional clinical circumstances, a physician may determine that the standard approved maximum dose of 20mg is insufficient for a specific patient. Severe underlying conditions, the degree of vascular impairment, or specific clinical factors may justify this decision. The doctor documents the clinical rationale, conducts comprehensive cardiovascular and metabolic assessment, rules out all correctable contributors to treatment failure, and monitors the patient closely throughout. This remains an individualized clinical decision and not a routine prescribing practice.
Vidalista 40mg delivers twice the Tadalafil dose of Vidalista 20mg. This produces stronger inhibition of PDE5, a greater blood vessel-dilating effect, and a more pronounced blood pressure-lowering effect. Vidalista 20mg is the approved maximum dose recognized by major international regulatory agencies. Vidalista 40mg exceeds this approved limit and therefore carries substantially greater safety considerations that require direct, ongoing, and expert medical supervision throughout its use.
Tadalafil at the 40mg dose reaches its peak blood concentration within 30 to 60 minutes of ingestion in most men. Some men notice effects within 20 to 30 minutes when taking the tablet on an empty stomach. The higher dose does not significantly accelerate the onset compared to the 20mg dose. However, the magnitude of the effect at peak concentration is greater at 40mg. Men should allow at least 30 to 45 minutes after taking the tablet before engaging in sexual activity.
The effects can last up to 36 hours, consistent with the known pharmacokinetics of Tadalafil. However, at the higher 40mg starting dose, the body takes longer to reduce Tadalafil blood concentrations to levels below clinical effect thresholds. Men must account for this extended systemic exposure when planning any subsequent dose. Managing interactions with other medicines during the elimination period also requires this awareness. The supervising doctor must factor these pharmacokinetic considerations into the overall treatment plan.
Men must not consume alcohol while taking Vidalista 40mg. Both Tadalafil and alcohol independently lower blood pressure. At the above-maximum 40mg dose, this blood pressure-lowering effect already surpasses that of approved dose levels. Adding alcohol amplifies this further and significantly increases the risk of dangerous blood pressure drops, severe dizziness, fainting, and serious cardiovascular events. Complete abstinence from alcohol is therefore necessary on any day a man takes Vidalista 40mg.
Men with diabetes considering Vidalista 40mg must undergo a thorough medical review before any use of this above-maximum dose. Diabetes often causes significant underlying vascular damage, autonomic neuropathy affecting blood pressure regulation, and polypharmacy with multiple interacting medicines. While Tadalafil at approved doses is widely used in diabetic men, the compounded risks of diabetic cardiovascular compromise and above-maximum Tadalafil dosing require especially careful individual evaluation by a qualified physician before any clinical decision is made.
Men who experience any concerning side effects after taking Vidalista 40mg must contact their supervising doctor immediately. Side effects such as prolonged or severe headache, persistent dizziness, chest discomfort, palpitations, significant vision changes, or back pain of unusual severity must never receive dismissal or self-management. Because this dose exceeds the approved maximum, the supervising doctor must receive prompt notification of any side effects. The doctor will then review, adjust, or discontinue the dose as clinically appropriate.
Men taking any nitrate medicine for heart disease or chest pain must never take Vidalista 40mg under any circumstances. Men with severe cardiovascular disease, a recent history of heart attack or stroke, very low blood pressure, severe liver disease, severe kidney impairment, or a known allergy to Tadalafil must not take this medicine. Men taking potent CYP3A4 inhibitors including certain antifungals, HIV medicines, and specific antibiotics must not combine these with Vidalista 40mg. Elderly men require particularly rigorous assessment before any use of this dose. This medicine is strictly for adult men only and must never be used by women or anyone under 18 years of age.
Mens Health
Mens Health
Mens Health
Mens HealthExplore Medicines
Select Using Category
